Roka Bioscience to participate in the 40th Annual National Food Policy Conference

Roka Bioscience to participate in the 40th Annual National Food Policy Conference

WARREN, N.J., April 10, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that Dr. Erin Dreyling, Vice President, Research & Scientific Affairs at Roka Bioscience will be a panelist in two sessions to be held at the 40th Annual National Food Policy Conference in Washington, DC.

Dr. Dreyling will be a panelist in the session entitled Big Data and the Future of Food Safety on Tuesday April 11th, 2017 at 11:15 AM ET.  Dr. Dreyling will also be a panelist on Wednesday, April 12th at 11:15 AM ET, in the session Food Industry Disruptors.

“I am excited to participate in the National Food Policy Conference in order to raise awareness about the important role that advanced pathogen detection technologies can play in improving food safety,” said Dr. Dreyling.

About the National Food Policy Conference

For decades, the National Food Policy Conference has been a Washington institution and a unique collaboration between consumer advocates, the food industry, and government. The conference is organized by the Consumer Federation of America and is a highly anticipated national gathering for those interested in agriculture, food and nutrition policy.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our “sample-in, result-out” Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. For more information, visit http://rokabio.com.

Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)

SOURCE Roka Bioscience